CLDN16 and COVID-19: Suppression of tight junction genes such as CLDN11, CLDN16, and CLDN18 suggests impaired epithelial barrier integrity, potentially enhancing vascular permeability and pulmonary edema, as reported in COVID-19-related lung injury (Hashimoto et al., 2022).